Sirius Investors

Insider Trading for MRNA

View recent insider trading activity including purchases, sales, and awards. Insider trading can provide insights into how executives view their company's prospects.

Insider Trading Summary

Shares Acquired1.3M
Past 100 transactions
Shares Disposed43.0K
Past 100 transactions
Net Position1.3M
Overall insider sentiment: bullish

Recent Activity (30 Days)

Acquisitions: 850 shares
Dispositions: 850 shares
Net: 0 shares

Recent insider activity has been balanced between buying and selling in the short term.

Quarterly Activity (3 Months)

Acquisitions: 8.6K shares
Dispositions: 12.6K shares
Net: -4.1K shares

Insiders have been net sellers over the quarter, which institutional investors may view as a cautionary signal.

Key Insider Activity: Feb 27, 2025 to Aug 5, 2025

Bancel Stephane
ExecutiveCorporate Officer
+517.4K shares
3 transactions
Hoge Stephen
ExecutivePresident
+387.6K shares
19 transactions
Mock James M
ExecutiveCorporate Officer
+98.2K shares
26 transactions
SAGAN PAUL
DirectorDirector
+57.1K shares
2 transactions
Klinger Shannon Thyme
ExecutiveCorporate Officer
+85.4K shares
29 transactions

Transaction Details

Show All
DateInsiderRoleTransactionSharesPriceValueOwned AfterSEC Filing
Aug 5, 2025Rubenstein David M.DDirectorExercise850$0.00$0.001.5KView
Aug 5, 2025Rubenstein David M.DDirectorExercise850$0.00$0.000View
Jul 3, 2025Mock James MECorporate OfficerExercise1.5K$0.00$0.0017.6KView
Jul 3, 2025Mock James MECorporate OfficerPayment In Kind703$30.28$21,286.8416.9KView
Jul 3, 2025Mock James MECorporate OfficerExercise1.5K$0.00$0.007.3KView
Jun 11, 2025Hussain AbbasDDirectorSale312$28.00$8,736.00580View
Jun 6, 2025Klinger Shannon ThymeECorporate OfficerExercise1.1K$0.00$0.0028.0KView
Jun 6, 2025Klinger Shannon ThymeECorporate OfficerPayment In Kind551$26.12$14,392.1227.5KView
Jun 6, 2025Klinger Shannon ThymeECorporate OfficerExercise1.1K$0.00$0.000View
May 30, 2025Hoge StephenEPresidentExercise652$0.00$0.001.5MView
Click "View" in the SEC Filing column to access the detailed SEC form submission for each transaction.

Executive Activity:

Executives have been net buyers of MRNA stock, which is typically a strong positive signal.